BSE Live
Dec 29, 12:24Prev. Close
2192.10
Open Price
2194.15
Bid Price (Qty.)
2185.35 (6)
Offer Price (Qty.)
2186.20 (1)
NSE Live
Dec 29, 12:24Prev. Close
2193.00
Open Price
2200.60
Bid Price (Qty.)
2185.30 (95)
Offer Price (Qty.)
2186.00 (3)
| Balance Sheet of Mankind Pharma (in Rs. Cr.) | Mar 09 | Mar 08 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 14.84 | 10.79 | |
| Total Share Capital | 14.84 | 10.79 | |
| Reserves and Surplus | 318.76 | 208.33 | |
| Total Reserves and Surplus | 318.76 | 208.33 | |
| Total Shareholders Funds | 333.59 | 219.12 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 7.27 | 9.17 | |
| Deferred Tax Liabilities [Net] | 1.81 | 1.10 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 9.09 | 10.27 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 0.00 | 0.00 | |
| Trade Payables | 0.00 | 0.00 | |
| Other Current Liabilities | 107.16 | 83.82 | |
| Short Term Provisions | 64.60 | 43.66 | |
| Total Current Liabilities | 171.76 | 127.49 | |
| Total Capital And Liabilities | 514.44 | 356.87 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 58.26 | 58.59 | |
| Intangible Assets | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.21 | 1.17 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 58.47 | 59.76 | |
| Non-Current Investments | 90.08 | 16.52 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.07 | 0.03 | |
| Total Non-Current Assets | 148.62 | 76.31 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 116.63 | 93.65 | |
| Trade Receivables | 70.77 | 59.60 | |
| Cash And Cash Equivalents | 59.61 | 57.47 | |
| Short Term Loans And Advances | 118.81 | 69.83 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 365.81 | 280.56 | |
| Total Assets | 514.44 | 356.87 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 7.41 | 1.94 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 0.18 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 0.92 | 0.63 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | -- | -- | |
| Other Earnings | -- | -- | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | 4.05 | -- | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | -- | -- | |
| Non-Current Investments Unquoted Book Value | 3.53 | 11.52 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y